Remepy

News

Remepy's hybrid Parkinson's therapy poised for phase 3

Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.

News

Merck partners Remepy in PDURS-focused alliance

Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.

Digital

Health Innovators – Or Shoval and Shahar Shelly

Why do the same medications work well in some patients and poorly in others? One reason might be the poorly understood connection between mind and body.

Remepy's hybrid Parkinson's therapy poised for phase 3

Merck partners Remepy in PDURS-focused alliance

Health Innovators – Or Shoval and Shahar Shelly

Jazz builds in epilepsy with $1.3bn Actio acquisition

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks